4956 unknown. 4956 Phase 2, 901 Phase 1, 302 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4956 | Unknown 4956 |
| Phase 1 | 901 | Unknown 901 |
| Phase 3 | 302 | Unknown 302 |
Follow Neoplasms: new trials by email Literature Review of Neoplasms trials Research Report on Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS) Metformin, Semaglutide Injectable Product - Polycystic Ovary Syndrome | Phase 2 / Phase 3 | Unknown | University of Hull | 60 | 2025-03-01 | 2024-05-10 |
| Cerebrospinal Fluid Immune Microenvironment Mechanism in Anaplastic Lymphoma Kinase Positive Lung Cancer Patients Iruplinalib - Carcinoma, Non-Small-Cell Lung | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 12 | 2024-12-01 | 2024-11-20 |
| Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer Anlotinib - Breast Cancer | Phase 2 | Unknown | The First Hospital of Jilin University | 40 | 2024-11-01 | 2024-11-07 |
| Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia Dasatinib Pill, Ketoconazole Pill - Chronic Myeloid Leukemia, Chronic Phase | Phase 2 | Unknown | Hospital Universitario Dr. Jose E. Gonzalez | 15 | 2024-11-01 | 2022-12-06 |
| Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic Intrathecal Pemetrexed - Small-cell Lung Cancer | Phase 2 | Unknown | Hunan Province Tumor Hospital | 80 | 2024-10-01 | 2024-09-19 |
| Node-Sparing Short-Course Radiation With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer: A Randomized, Prospective, Multicenter Study Node-Sparing Short-Course Radiotherapy Combined with CAPOX and Sintilimab, CAPOX Chemotherapy - Microsatellite Stable (MSS) Colon Cancer, Locally Advanced Colon Cancer | Phase 2 | Unknown | Sir Run Run Shaw Hospital | 140 | 2024-10-01 | 2024-09-19 |
| A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients. Lutetium-177-DOTAGA-IAC - Breast Cancer Stage IV | Phase 1 / Phase 2 | Unknown | Advanced Imaging Projects, LLC | 100 | 2024-09-30 | 2024-04-10 |
| Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases Intrathecal Pemetrexed and high-dose Furmonertinib plus bevacizumab - Non-small Cell Lung Cancer | Phase 2 | Unknown | Hunan Province Tumor Hospital | 30 | 2024-09-30 | 2024-09-20 |
| BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma BTLA inhibitor (JS004), Toripalimab, Paclitaxel, Cisplatin - Esophageal Squamous Cell Carcinoma | Phase 2 | Unknown | Henan Provincial People's Hospital | 20 | 2024-09-30 | 2024-09-19 |
| A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer SHR-A2102, Adebelimab (SHR-1316), SHR-8068 - Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Unknown | Shanghai Hengrui Pharmaceutical Co., Ltd. | 124 | 2024-09-27 | 2024-11-12 |
| PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) PH009-1 tablet - Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | Unknown | Suzhou Puhe Pharmaceutical Technology Co., LTD | 96 | 2024-09-10 | 2024-09-19 |
| Pharmacoscopy-guided Clinical Standard-of-care in r/r AML Pharmacoscopy, Clinical standard-of-care (physician's choice) - AML, Adult | Phase 2 | Unknown | ETH Zurich | 88 | 2024-09-02 | 2025-05-16 |
| Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer RC48/Carboplatin - Ovarian Cancer | Phase 2 | Unknown | Sun Yat-sen University | 47 | 2024-09-01 | 2024-08-28 |
| A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or Ablation Camrelizumab, Apatinib - Hepatocellular Carcinoma | Phase 2 | Unknown | Zhujiang Hospital | 38 | 2024-08-26 | 2024-08-09 |
| Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping Fluzoparib, Everolimus, Fulvestrant - Breast Cancer | Phase 2 | Unknown | Fudan University | 260 | 2024-08-21 | 2024-08-19 |
| Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study FOLFOXIRI Protocol - Neoplasm Malignant, Colon Cancer Stage 4 | Phase 2 | Unknown | Al-Azhar University | 60 | 2024-08-17 | 2024-08-28 |
| Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis) Aminolevulinic acid hydrochloride 10% topical gel with Red Light - Cutaneous Squamous Cell Carcinoma | Phase 2 | Unknown | The Center for Clinical and Cosmetic Research | 20 | 2024-08-14 | 2024-08-29 |
| Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations Neratinib tablets - Advanced Solid Tumor | Phase 2 | Unknown | Convalife (Shanghai) Co., Ltd. | 60 | 2024-08-10 | 2024-07-25 |
| Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer Irinotecan Liposome, Bevacizumab - Metastatic Colorectal Cancer | Phase 1 / Phase 2 | Unknown | West China Hospital | 20 | 2024-08-09 | 2024-08-09 |
| The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy Receive Abiraterone plus prednisone/Enzalutamide/Apalutamide/Rezvilutamide in the evening - Prostate Cancer | Phase 2 | Unknown | Sun Yat-sen University | 70 | 2024-08-01 | 2024-08-05 |
Showing 20 of 4956. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (489) · Breast Neoplasms (463) · Colorectal Neoplasms (324) · Stomach Neoplasms (285) · Carcinoma, Hepatocellular (241) · Lung Neoplasms (164) · Pancreatic Neoplasms (162) · Leukemia, Myeloid, Acute (151) · Neoplasm Metastasis (150) · Prostatic Neoplasms (148) · Recurrence (136) · Multiple Myeloma (131) · Lymphoma (125) · Ovarian Neoplasms (124)
Neoplasms by Site (3571) · Neoplasms by Histologic Type (2177) · Digestive System Diseases (1410) · Digestive System Neoplasms (1376) · Neoplasms, Glandular and Epithelial (1042) · Gastrointestinal Diseases (955) · Gastrointestinal Neoplasms (922) · Hemic and Lymphatic Diseases (873) · Carcinoma (849) · Respiratory Tract Neoplasms (709) · Respiratory Tract Diseases (708) · Thoracic Neoplasms (707) · Lung Diseases (685) · Skin and Connective Tissue Diseases (654)
Cisplatin (290) · Carboplatin (205) · Capecitabine (192) · Docetaxel (189) · Oxaliplatin (186) · Paclitaxel (180) · Cyclophosphamide (178) · Radiotherapy (177) · Gemcitabine (169) · apatinib (168) · camrelizumab (156) · Bevacizumab (155) · Fluorouracil (144) · Drug Therapy (134) · sintilimab (114)
Fudan University (182) · Sun Yat-sen University (182) · Tianjin Medical University Cancer Institute and Hospital (77) · Chinese Academy of Medical Sciences (74) · Peking Union Medical College Hospital (67) · Zhejiang Cancer Hospital (67) · Samsung Medical Center (55) · Chinese PLA General Hospital (52) · National University Hospital, Singapore (41) · National Cancer Center, Korea (39) · Yonsei University (37) · Peking University (36) · Second Affiliated Hospital, Zhejiang University, School of Medicine (35) · The First Affiliated Hospital with Nanjing Medical University (35) · Henan Cancer Hospital (33)
China (2222) · United States (515) · South Korea (294) · Italy (187) · France (152) · United Kingdom (143) · Germany (140) · Spain (104) · Netherlands (96) · Canada (95) · Taiwan (86) · Israel (71) · Singapore (62) · Belgium (61) · Australia (59)
Lei Li, M.D. (10) · Cheng Qian, MD, PhD (8) · Cheng Qian, PhD (8) · Binghe Xu (7) · Ye Guo, MD (7) · Yuankai Shi, MD (7) · Feng Wang (6) · Lin Shen, MD (6) · Robert N. Taub, MD, PhD (6) · Sanbin Wang, MD (6) · Ulrich Keilholz, MD (6) · Francesco Perrone, M.D., Ph.D. (5) · Joo-Hang Kim, MD (5) · Jun Guo, MD (5) · Lin Shen, Professor (5)
PMID 34515338, PMID 19097774, PMID 30207593, PMID 26884585, PMID 28054442, PMID 30642373, PMID 37185961, PMID 25303679, PMID 25789053, PMID 33990415, PMID 35623069, PMID 40135712, PMID 41671463, PMID 12049862, PMID 12540794, PMID 15273542, PMID 16011702, PMID 16172198, PMID 16204011, PMID 17075123, PMID 18268546, PMID 19188168, PMID 19299237, PMID 19692680, PMID 19819917, PMID 20087581, PMID 20375404, PMID 20516446, PMID 21183517, PMID 23547081, PMID 24529560, PMID 25092775, PMID 25447852, PMID 25497558, PMID 25514302, PMID 26104945, PMID 26313683, PMID 26755520, PMID 27480145, PMID 27872127, PMID 28434648, PMID 29433850, PMID 29438373, PMID 30348638, PMID 30596880, PMID 31039052, PMID 31085043, PMID 31401903, PMID 31751012, PMID 32306237
2016 (25), 2017 (20), 2015 (17), 2018 (15), 2014 (14), 2019 (13), 2009 (10), P30CA060553 (8), 2008 (6), P30CA015083 (6), 2005 (4), 2004 (2), M01RR000096 (2), P30CA022453 (2), P30CA033572 (2)